Inogen Inc (INGN)
6.73
-0.32
(-4.54%)
USD |
NASDAQ |
Apr 25, 11:12
Inogen Revenue (Quarterly): 75.90M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 75.90M |
| September 30, 2023 | 83.97M |
| June 30, 2023 | 83.64M |
| March 31, 2023 | 72.16M |
| December 31, 2022 | 88.09M |
| September 30, 2022 | 105.39M |
| June 30, 2022 | 103.38M |
| March 31, 2022 | 80.38M |
| December 31, 2021 | 76.40M |
| September 30, 2021 | 93.10M |
| June 30, 2021 | 101.56M |
| March 31, 2021 | 86.93M |
| December 31, 2020 | 73.98M |
| September 30, 2020 | 74.33M |
| June 30, 2020 | 71.69M |
| March 31, 2020 | 88.49M |
| December 31, 2019 | 78.92M |
| September 30, 2019 | 91.76M |
| June 30, 2019 | 101.06M |
| March 31, 2019 | 90.20M |
| December 31, 2018 | 86.53M |
| September 30, 2018 | 95.29M |
| June 30, 2018 | 97.24M |
| Date | Value |
|---|---|
| March 31, 2018 | 79.05M |
| December 31, 2017 | 63.79M |
| September 30, 2017 | 69.03M |
| June 30, 2017 | 64.12M |
| March 31, 2017 | 52.50M |
| December 31, 2016 | 50.85M |
| September 30, 2016 | 54.42M |
| June 30, 2016 | 54.57M |
| March 31, 2016 | 42.99M |
| December 31, 2015 | 40.45M |
| September 30, 2015 | 40.78M |
| June 30, 2015 | 44.03M |
| March 31, 2015 | 33.75M |
| December 31, 2014 | 29.12M |
| September 30, 2014 | 29.39M |
| June 30, 2014 | 30.39M |
| March 31, 2014 | 23.63M |
| December 31, 2013 | 19.76M |
| September 30, 2013 | 19.78M |
| June 30, 2013 | 20.16M |
| March 31, 2013 | 15.75M |
| December 31, 2012 | 13.84M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
71.69M
Minimum
Jun 2020
105.39M
Maximum
Sep 2022
85.85M
Average
83.97M
Median
Sep 2023
Revenue (Quarterly) Benchmarks
| Oragenics Inc | -- |
| Palatin Technologies Inc | 2.034M |
| Oramed Pharmaceuticals Inc | -- |
| vTv Therapeutics Inc | -- |
| G1 Therapeutics Inc | 14.87M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -26.56M |
| Total Expenses (Quarterly) | 104.88M |
| EPS Diluted (Quarterly) | -1.14 |
| Enterprise Value | 35.98M |
| Gross Profit Margin (Quarterly) | 37.10% |
| Profit Margin (Quarterly) | -34.99% |
| Earnings Yield | -65.53% |
| Normalized Earnings Yield | -48.91 |